MedTrace Logo

ROTEM in Patients With Placenta Previa

NCT04213755 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-11-02

No results posted yet for this study

Summary

The rotational thromboelastogram (ROTEM) test can be performed on patients with placenta previa/accreta/increta/percreta who have a high likelihood of massive bleeding, and the predictors can be identified by comparing the patients who actually show massive bleeding with those who do not.

Applying these predictive factors to pregnant women undergoing cesarean section after diagnosis of placenta previa/accreta/increta/percreta, it will be advantageous for the perioperative management because it is possible to select pregnant women with a factor of massive bleeding.

Conditions

  • Placenta Previa
  • Placenta Accreta
  • Placenta Increta
  • Placenta Percreta

Interventions

DIAGNOSTIC_TEST

ROTEM

ROTEM including INTEM, EXTEM, APTEM, and FIBTEM

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2022-08-31
Completion
2022-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04213755 on ClinicalTrials.gov